UroGen Pharma Ltd. (URGN)
21.80
-0.56
(-2.50%)
USD |
NASDAQ |
Dec 12, 16:00
21.79
-0.01
(-0.05%)
After-Hours: 20:00
UroGen Pharma Profit Margin (Quarterly): -121.3% for Sept. 30, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Biogen, Inc. | 19.00% |
| MeiraGTx Holdings Plc | -12.32K% |
| CEL-SCI Corp. | -- |
| AIM ImmunoTech, Inc. | -12.63K% |
| IGC Pharma, Inc. | -953.4% |
Profit Margin (Quarterly) Related Metrics
| Return on Assets | -66.98% |
| Return on Invested Capital | -209.5% |
| Gross Profit Margin (Quarterly) | 88.07% |
| Operating Margin (Quarterly) | -99.65% |
| Return on Net Operating Assets | -489.3% |